Update on Acromegaly: Treatment Based on the New Guidelines

Session Description: This session will discuss the best strategy to treat patients with acromegaly according to new guidelines and in light of the availability (or not) of biomarkers and new drugs.

Faculty: Shlomo Melmed, MB ChB
Cedar Sinai Medical Center

Learning Objectives:

1. Translate relevant data published from the new guidelines.
2. Discuss potential benefits and limitations of biomarkers in drug choice.
3. Describe the new drugs in the horizon (with special emphasis on the recently FDA approved oral octreotide—which patient will benefit from this drug?).

Return to the full CEU program.